| ★ |  VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | |
| 9 |  ApoB Explained: What Your LDL Test Doesn’t Tell You | Metabolic Mind @metabolicmind | — | Estados Unidos | 85 |
| 14 |  Q&A: Cholesterol, CRP, & Ketogenic Therapy — A Cardiologist Weighs In | Metabolic Mind @metabolicmind | — | Estados Unidos | 85 |
| 17 |  Cardiólogo Revela: Este Medicamento Causa infarto y ACV en Adultos Mayores | | 332.8K | México | 85 |
| 1 |  The Cholesterol War Is Over (Here's Who Won) | Dr Brad Stanfield @drbradstanfield | 147.6K | Nueva Zelanda | 87 |
| 2 |  GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals | Metabolic Mind @metabolicmind | 49.3K | Estados Unidos | 86 |
| 20 |  The Statin Paradox: Why This Drug Doesn't Help Most Patients | Mark Hyman, MD @drmarkhyman | 42.5K | Estados Unidos | 85 |
| 12 |  Rethinking Cholesterol Risk: What Lean Mass Hyper-Responders Reveal | Metabolic Mind @metabolicmind | 7.9K | Estados Unidos | 85 |
| 8 |  Imagerie coronaire et prévention : le coroscanner, pour qui ? | Cardio-online @cardio-online9873 | 2.2K | Francia | 85 |
| 15 |  Cholesterol Guidelines Just Changed (2026)- Earlier Screening & Prevention Explained | Blossom Family Medicine @blossomfamilymed | 1.6K | Estados Unidos | 85 |
| 6 |  Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential | | 839 | Estados Unidos | 85 |
| 10 |  Inside Longevity Clinics What Is Real and What Is Hype | Medical Centric Podcast @medicalcentric | 650 | Portugal | 85 |
| 13 |  Prévention cardiovasculaire, comment passer à l'action ? | Cardio-online @cardio-online9873 | 573 | Francia | 85 |
| 7 |  Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 85 |
| 16 |  TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 85 |
| 11 |  Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026 | | 224 | Estados Unidos | 85 |
| 3 |  Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3 | | 158 | Estados Unidos | 86 |
| 19 |  Presente y futuro de la Lipoproteína (a) en salud cardiovascular | Instituto de Efectividad Clínica y Sanitaria @institutodeefectividadclin1489 | 139 | Argentina | 85 |
| 5 |  AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines | | 129 | Estados Unidos | 85 |
| 18 |  MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins | | 86 | Estados Unidos | 85 |
| 4 |  Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction | | 29 | Estados Unidos | 86 |